US Patent 7750141 Modulation of apolipoprotein c-III expression
Patent 7750141 was granted and assigned to Ionis Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7750141 Modulation of apolipoprotein c-III expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.